GLP‐1 receptor agonists in patients with MGUS: A real‐world propensity‐matched study

Anastasios Tentolouris; Ioannis Ntanasis‐Stathopoulos; Charalampos Filippatos; Evangelos Terpos; Efstathios Kastritis; Ernesto Ruiz Duque; Meletios A Dimopoulos; Maria Gavriatopoulou; Αlexandros Briasoulis

doi:10.1111/eci.70140

Related publications

Article2025

<scp>GLP</scp> ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity

Tommaso Bucci, Uazman Alam, Grégoire Fauchier, Lisa Lochon, Arnaud Bisson, Pierre Henri Ducluzeau, Professor Gregory Lip, Laurent Fauchier

Article2025

Clinical Outcomes of Patients with MGUS and Diabetes/Obesity on GLP-1 Receptor Agonists: A Real-World, Propensity-Matched Study

Ioannis Ntanasis‐Stathopoulos, Anastasios Tentolouris, Charalampos Filippatos, Αlexandros Briasoulis, Meletios A Dimopoulos, Maria Gavriatopoulou

Article2024

Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia.

Claudia Angela Maria Fulgenzi, Talal El Zarif, Amin Nassar, Elio Adib, Joaquim Bellmunt, Thomas U. Marron, Michael Lorentsen, Rana R. McKay, Javier Baena, Celina Ang, Lorenza Rimassa, Masatoshi Kudo, Alessandro Parisi, Anwaar Saeed, Pei‐Chang Lee, Neehar D. Parikh, Matthias Pinter, Alessio Cortellini, Abdul Rafeh Naqash, David J. Pinato

Article2025

Risk of all–cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network

Enrico Tartaglia, Tommaso Bucci, Michele Rossi, Andrea Galeazzo Rigutini, Amir Askarinejad, Uazman Alam, Katarzyna Nabrdalik, Giuseppe Boriani, Professor Gregory Lip

Article2018

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

Eirini Katodritou, Evangelos Terpos, Sossana Delimpasi, Maria Kotsopoulou, Eurydiki Michalis, Chrysanthi Vadikolia, Marie‐Christine Kyrtsonis, Argiris Symeonidis, Nikolaos Giannakoulas, Chrissa Vadikolia, Michalis Michael, Christina Kalpadakis, Theodora Gougopoulou, Chrystalla Prokopiou, Georgia Kaiafa, Dimitrios Christoulas, Maria Gavriatopoulou, Evlampia Giannopoulou, Vasiliki Labropoulou, Evgenia Verrou, Efstathios Kastritis, ,

GLP‐1 receptor agonists in patients with MGUS: A real‐world propensity‐matched study

Abstract

Discussion(0)

Related publications

<scp>GLP</scp> ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity

Clinical Outcomes of Patients with MGUS and Diabetes/Obesity on GLP-1 Receptor Agonists: A Real-World, Propensity-Matched Study

Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia.

Risk of all–cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network

Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group